Cargando…

2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations

BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chengcheng, Feng, Yu, Zong, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678721/
http://dx.doi.org/10.1093/ofid/ofad500.1811
_version_ 1785150430291951616
author Wang, Chengcheng
Feng, Yu
Zong, Zhiyong
author_facet Wang, Chengcheng
Feng, Yu
Zong, Zhiyong
author_sort Wang, Chengcheng
collection PubMed
description BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine whether CHR leads to treatment failure, we conducted in vitro time-killing assays and in vivo assays using murine intra-abdominal infection models. To determine the genetic mechanism for the CHR phenotype, we conducted whole-genome sequencing and ultra-deep second-generation sequencing. A schematic outline of methods and main results [Figure: see text] RESULTS: In this study, we found that 30% of Enterobacter clinical strains causing bloodstream infections at West China Hospital exhibited CHR, which was associated with treatment failure and fatal infections, as demonstrated by in vitro time-kill tests and in vivo mouse infection modeling. We identified base alterations in the phoP-phoQ gene as the main resistance mechanism in Enterobacter CHR and that this heterogeneity originated from colistin selection and base heterozygosity, as detected by ultra-deep second-generation sequencing. We also found that several different resistance subpopulations existed simultaneously in the same strain with different resistance mechanisms. Time-kill experiments in Enterobacter isolates with CHR or susceptible to colistin [Figure: see text] CHR strains lead to in vivo colistin treatment failure [Figure: see text] Phenotypic and genomic study of a CHR strain [Figure: see text] CONCLUSION: We presented evidence for "genetic heterogeneity" in Enterobacter CHR strains, which is consistent with "phenotypic heterogeneity" and genetically explains the unstable and transient HR. This provides important insights and a fresh perspective into the mechanisms and clinical implications of Enterobacter CHR and underscores the importance of deep sequencing, prompting the research of high-throughput microbial single-cell sequencing as a method for detecting "genetic heterogeneity." Frequency of bases that mediate colistin resistance at the same locus of phoP-Q in the parental and resistant strains [Figure: see text] DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106787212023-11-27 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations Wang, Chengcheng Feng, Yu Zong, Zhiyong Open Forum Infect Dis Abstract BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine whether CHR leads to treatment failure, we conducted in vitro time-killing assays and in vivo assays using murine intra-abdominal infection models. To determine the genetic mechanism for the CHR phenotype, we conducted whole-genome sequencing and ultra-deep second-generation sequencing. A schematic outline of methods and main results [Figure: see text] RESULTS: In this study, we found that 30% of Enterobacter clinical strains causing bloodstream infections at West China Hospital exhibited CHR, which was associated with treatment failure and fatal infections, as demonstrated by in vitro time-kill tests and in vivo mouse infection modeling. We identified base alterations in the phoP-phoQ gene as the main resistance mechanism in Enterobacter CHR and that this heterogeneity originated from colistin selection and base heterozygosity, as detected by ultra-deep second-generation sequencing. We also found that several different resistance subpopulations existed simultaneously in the same strain with different resistance mechanisms. Time-kill experiments in Enterobacter isolates with CHR or susceptible to colistin [Figure: see text] CHR strains lead to in vivo colistin treatment failure [Figure: see text] Phenotypic and genomic study of a CHR strain [Figure: see text] CONCLUSION: We presented evidence for "genetic heterogeneity" in Enterobacter CHR strains, which is consistent with "phenotypic heterogeneity" and genetically explains the unstable and transient HR. This provides important insights and a fresh perspective into the mechanisms and clinical implications of Enterobacter CHR and underscores the importance of deep sequencing, prompting the research of high-throughput microbial single-cell sequencing as a method for detecting "genetic heterogeneity." Frequency of bases that mediate colistin resistance at the same locus of phoP-Q in the parental and resistant strains [Figure: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678721/ http://dx.doi.org/10.1093/ofid/ofad500.1811 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Wang, Chengcheng
Feng, Yu
Zong, Zhiyong
2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title_full 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title_fullStr 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title_full_unstemmed 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title_short 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
title_sort 2189. colistin heteroresistance in enterobacter due to base heterozygosity at certain phopq locations
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678721/
http://dx.doi.org/10.1093/ofid/ofad500.1811
work_keys_str_mv AT wangchengcheng 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations
AT fengyu 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations
AT zongzhiyong 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations